.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Colorcon
UBS
Teva
Chinese Patent Office
Harvard Business School
Boehringer Ingelheim
Baxter
Healthtrust

Generated: June 22, 2017

DrugPatentWatch Database Preview

Nebivolol hydrochloride; valsartan - Generic Drug Details

« Back to Dashboard

What are the generic sources for nebivolol hydrochloride; valsartan and what is the scope of nebivolol hydrochloride; valsartan freedom to operate?

Nebivolol hydrochloride; valsartan
is the generic ingredient in one branded drug marketed by Forest Labs Llc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Nebivolol hydrochloride; valsartan has thirty-nine patent family members in fifteen countries.

There are fourteen drug master file entries for nebivolol hydrochloride; valsartan. One supplier is listed for this compound.

Summary for Generic Name: nebivolol hydrochloride; valsartan

Tradenames:1
Patents:3
Applicants:1
NDAs:1
Drug Master File Entries: see list14
Suppliers / Packagers: see list1
Clinical Trials: see list2,575
Drug Prices:see low prices
DailyMed Link:nebivolol hydrochloride; valsartan at DailyMed

Pharmacology for Ingredient: nebivolol hydrochloride; valsartan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs Llc
BYVALSON
nebivolol hydrochloride; valsartan
TABLET;ORAL206302-001Jun 3, 2016RXYesYes► Subscribe► Subscribe
Forest Labs Llc
BYVALSON
nebivolol hydrochloride; valsartan
TABLET;ORAL206302-001Jun 3, 2016RXYesYes7,803,838► SubscribeY ► Subscribe
Forest Labs Llc
BYVALSON
nebivolol hydrochloride; valsartan
TABLET;ORAL206302-001Jun 3, 2016RXYesYes7,838,552► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: nebivolol hydrochloride; valsartan

Country Document Number Estimated Expiration
European Patent Office1982711► Subscribe
New Zealand551910► Subscribe
World Intellectual Property Organization (WIPO)2005117858► Subscribe
Israel187552► Subscribe
African Regional IP Organization (ARIPO)2896► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: NEBIVOLOL HYDROCHLORIDE; VALSARTAN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB96/048United Kingdom► SubscribePRODUCT NAME: NEBIVOLOL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR HYDRATE; REGISTERED: NL RVG/19317 19951018; UK 00242/0309 19960509
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Colorcon
Daiichi Sankyo
Fish and Richardson
Dow
Farmers Insurance
Citi
Chinese Patent Office
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot